Avicanna USA Inc. together with Avicanna Inc. announced the appointment of Stephen Kim as the Avicanna's Chief Legal Officer & General Counsel. Mr. Kim comes with over twenty years of legal experience with highly regulated and innovative industries. He has significant pharmaceutical industry experience and is very familiar with the complex overlay of corporate, commercial, IP, governance, compliance, and regulatory considerations associated with development, approval, and launch of multiple pharmaceutical products, which he has executed in the US, Canada, and globally.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.235 CAD | 0.00% | -4.08% | -32.86% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.86% | 16.78M | |
+55.70% | 59.34B | |
+41.08% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- AVCN Stock
- News Avicanna Inc.
- Avicanna Inc. the Appointment of Stephen Kim as Chief Legal Officer & General Counsel